Pro Medicus (PME), a current holding within the value component of the ASX Growth portfolio, has this morning reported interim results. Despite a robust performance for the first half of the fiscal year, shares are -4.99% lower this morning, likely reflecting profit-taking from investors following a surge over the past four months, as well as lofty expectations.
Pro Medicus Limited (PME:ASX)
Last update - 15 February 2024
By James Woods